Global climate change has prompted efforts to drastically reduce emissions of carbon dioxide, a greenhouse gas produced by burning fossil fuels.
In a new approach, researchers from the UCLA Henry Samueli School of Engineering and Applied Science have genetically modified a cyanobacterium to consume carbon dioxide and produce the liquid fuel isobutanol, which holds great potential as a gasoline alternative. The reaction is powered directly by energy from sunlight, through photosynthesis.
The research appears in the Dec. 9 print edition of the journal Nature Biotechnology and is available online.
This new method has two advantages for the long-term, global-scale goal of achieving a cleaner and greener energy economy, the researchers say. First, it recycles carbon dioxide, reducing greenhouse gas emissions resulting from the burning of fossil fuels. Second, it uses solar energy to convert the carbon dioxide into a liquid fuel that can be used in the existing energy infrastructure, including in most automobiles.
While other alternatives to gasoline include deriving biofuels from plants or from algae, both of these processes require several intermediate steps before refinement into usable fuels.
"This new approach avoids the need for biomass deconstruction, either in the case of cellulosic biomass or algal biomass, which is a major economic barrier for biofuel production," said team leader James C. Liao, Chancellor's Professor of Chemical and Biomolecular Engineering at UCLA and associate director of the UCLA-Department of Energy Institute for Genomics and Proteomics. "Therefore, this is potentially much more efficient and less expensive than the current approach."
Using the cyanobacterium Synechoccus elongatus, researchers first genetically increased the quantity of the carbon dioxide-fixing enzyme RuBisCO. Then they spliced genes from other microorganisms to engineer a strain that intakes carbon dioxide and sunlight and produces isobutyraldehyde gas. The low boiling point and high vapor pressure of the gas allows it to easily be stripped from the system.
The engineered bacteria can produce isobutanol directly, but researchers say it is currently easier to use an existing and relatively inexpensive chemical catalysis process to convert isobutyraldehyde gas to isobutanol, as well as other useful petroleum-based products.
In addition to Liao, the research team included lead author Shota Atsumi, a former UCLA postdoctoral scholar now on the UC Davis faculty, and UCLA postdoctoral scholar Wendy Higashide.
An ideal place for this system would be next to existing power plants that emit carbon dioxide, the researchers say, potentially allowing the greenhouse gas to be captured and directly recycled into liquid fuel.
"We are continuing to improve the rate and yield of the production," Liao said. "Other obstacles include the efficiency of light distribution and reduction of bioreactor cost. We are working on solutions to these problems."
More information: Nature Biotechnology paper: http://www.nature.com/nbt/journal/v27/n12/abs/nbt.1586.html
- Posted using BlogPress from my iPhone
Welcome
A blog for thoughts on life, and discussions of life events . . . .
Comments and views are welcomed, within the realms of good taste and legal neutrality.
Comments and views are welcomed, within the realms of good taste and legal neutrality.
Saturday, 12 December 2009
Friday, 4 December 2009
The Strata-Sphere » The AGW Cover Up Is In The Code – Smoking Gun Update!
Anthropogenic Global Warming - what belies the truth?
Thursday, 3 December 2009
Self assembly poinsettia
I didn’t realise this was a self assembly poinsettia when I bought it from Somerfield/Co-op in Pocklington. Not to worry though as they say I can return it for a replacement fully assembled version. It cost £3.75. The 10 mile car journey that will also take an irreplaceable 1/2 hour of my life is something that I look forward to with Christmas glee! British grown, British broken and British dissatisfied customer. Merry British Christmas! Oh sorry, it’s not British to say that is it? Merry British Festival of Light! And up your Merry British Arses!
Tuesday, 17 November 2009
Rare brain disorder that causes dementia is hereditary
New research shows that a rare brain disorder that causes early dementia is highly hereditary. The brain disorder, called frontotemporal dementia, is formerly known as Pick's disease and destroys parts of the brain, leading to dementia, including problems with language or changes in behavior and personality. The disease often affects people under the age of 65. The study is published in the November 3, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.
Monday, 16 November 2009
Violating Homeopaths
The Society of Homeopaths is in breach of its own code of ethics by posting "speculative," "misleading," and "deceptive" statements on its website, claims a leading UK expert in complementary medicine.
Edzard Ernst, professor of complementary medicine at the Peninsula Medical School in Exeter, identified numerous statements on the society’s website that he claimed could be seen as contravening the code. He was writing in the International Journal of Clinical Practice (doi:10.1111/j.1742-1241.2009.02249.x).
The code of ethics, which runs to 23 pages, sets out the rules that the society expects its members to abide by. These state that advertising should not make claims to "cure named diseases" or be "false, fraudulent, misleading, deceptive, extravagant or sensational." It adds that "all speculative theories will be stated as such and clearly distinguished."
However, a review of some members’ websites showed a series of violations
Edzard Ernst, professor of complementary medicine at the Peninsula Medical School in Exeter, identified numerous statements on the society’s website that he claimed could be seen as contravening the code. He was writing in the International Journal of Clinical Practice (doi:10.1111/j.1742-1241.2009.02249.x).
The code of ethics, which runs to 23 pages, sets out the rules that the society expects its members to abide by. These state that advertising should not make claims to "cure named diseases" or be "false, fraudulent, misleading, deceptive, extravagant or sensational." It adds that "all speculative theories will be stated as such and clearly distinguished."
However, a review of some members’ websites showed a series of violations
Subscribe to:
Comments (Atom)
